|
C17ORF71 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.4484004540758E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.88737914186277E-15 |
| Normal-vs-Stage2 |
6.503800E-03 |
| Normal-vs-Stage3 |
3.136400E-02 |
| Normal-vs-Stage4 |
7.214000E-02 |
| Stage1-vs-Stage2 |
2.074300E-02 |
| Stage1-vs-Stage3 |
2.33210000000206E-06 |
| Stage1-vs-Stage4 |
7.83400000000656E-05 |
| Stage2-vs-Stage3 |
2.935000E-01 |
| Stage2-vs-Stage4 |
3.383000E-01 |
| Stage3-vs-Stage4 |
9.937000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.89649987223117E-10 |
| Normal-vs-AfricanAmerican |
6.464400E-03 |
| Normal-vs-Asian |
2.027200E-01 |
| Caucasian-vs-AfricanAmerican |
5.474400E-01 |
| Caucasian-vs-Asian |
8.776800E-01 |
| AfricanAmerican-vs-Asian |
9.350800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.13710000029899E-07 |
| Normal-vs-Female |
3.16910053754782E-10 |
| Male-vs-Female |
2.997800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.234410E-01 |
| Normal-vs-Age(41-60Yrs) |
7.79370001868784E-09 |
| Normal-vs-Age(61-80Yrs) |
2.81950000013964E-08 |
| Normal-vs-Age(81-100Yrs) |
1.568360E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.736800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.687000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.588000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.034600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.443000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.457800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.36528632422551E-12 |
| Normal-vs-Grade 2 |
1.713407193904E-12 |
| Normal-vs-Grade 3 |
3.59280000000739E-05 |
| Normal-vs-Grade 4 |
6.309000E-01 |
| Grade 1-vs-Grade 2 |
4.314100E-02 |
| Grade 1-vs-Grade 3 |
1.318950E-03 |
| Grade 1-vs-Grade 4 |
3.94369999999755E-05 |
| Grade 2-vs-Grade 3 |
9.242600E-04 |
| Grade 2-vs-Grade 4 |
7.84839999989906E-07 |
| Grade 3-vs-Grade 4 |
1.320290E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
1.148390E-02 |
| ccA subtype-vs-ccB subtype |
1.35510003218542E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.12680000277743E-08 |
| Normal-vs-N1 |
2.729600E-01 |
| N0-vs-N1 |
5.499200E-01 |
|
|
